Vinodh Srinivasasainagendra
Overview
Explore the profile of Vinodh Srinivasasainagendra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
756
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilson A, Rocco A, Chiles J, Srinivasasainagendra V, Labaki W, Meyers D, et al.
PLoS Genet
. 2025 Feb;
21(2):e1011531.
PMID: 39919125
Chronic obstructive pulmonary disease (COPD) is a leading cause of death globally. Gastroesophageal reflux disease (GERD) is a common comorbidity in COPD associated with worse pulmonary symptoms, reduced quality of...
2.
Aroke E, Nagidi J, Srinivasasainagendra V, Quinn T, Agbor F, Kinnie K, et al.
J Pain Res
. 2024 Dec;
17:4317-4329.
PMID: 39712464
Introduction: Having a lower socioeconomic status (SES) is a predictor of age-related chronic conditions, including chronic low back pain (cLBP). We aimed to examine whether the pace of biological aging...
3.
Freij K, Agbor F, Kinnie K, Srinivasasainagendra V, Quinn T, Tiwari H, et al.
Neurobiol Pain
. 2024 Nov;
16:100170.
PMID: 39507011
This study aimed to determine the nature of the relationship between the internalized stigma of chronic pain (ISCP), the pace of biological aging, and racial disparities in nonspecific chronic low...
4.
Armstrong N, Srinivasasainagendra V, Patki A, Jones A, Parcha V, Pampana A, et al.
JAMA Cardiol
. 2024 Oct;
9(12):1134-1141.
PMID: 39441603
Importance: The clinical utility of polygenic risk scores (PRS) for blood pressure (BP) response to antihypertensive treatment (AHT) has not been elucidated. Objective: To investigate the ability of a systolic...
5.
Jones A, Patki A, Srinivasasainagendra V, Hidalgo B, Tiwari H, Limdi N, et al.
Sci Rep
. 2024 Jul;
14(1):17757.
PMID: 39085340
Chronic kidney disease (CKD) impacts about 1 in 7 adults in the United States, but African Americans (AAs) carry a disproportionately higher burden of disease. Epigenetic modifications, such as DNA...
6.
Jones A, Patki A, Srinivasasainagendra V, Tiwari H, Armstrong N, Chaudhary N, et al.
J Am Soc Nephrol
. 2024 Jul;
35(11):1558-1569.
PMID: 39073889
No abstract available.
7.
Armstrong N, Patki A, Srinivasasainagendra V, Ge T, Lange L, Kottyan L, et al.
Sci Rep
. 2024 Jun;
14(1):14009.
PMID: 38890458
Type 2 diabetes (T2D) is caused by both genetic and environmental factors and is associated with an increased risk of cardiorenal complications and mortality. Though disproportionately affected by the condition,...
8.
Shrestha S, Wiener H, Chowdhury S, Kajimoto H, Srinivasasainagendra V, Mamaeva O, et al.
NPJ Genom Med
. 2024 May;
9(1):34.
PMID: 38816462
Kawasaki disease (KD) is a multisystem inflammatory illness of infants and young children that can result in acute vasculitis. The mechanism of coronary artery aneurysms (CAA) in KD despite intravenous...
9.
Pang L, Cai C, Aggarwal P, Wang D, Vijay V, Bagam P, et al.
Toxicol Sci
. 2024 Mar;
200(1):79-94.
PMID: 38547396
Many oncology drugs have been found to induce cardiotoxicity in a subset of patients, which significantly limits their clinical use and impedes the benefit of lifesaving anticancer treatments. Human induced...
10.
Irvin M, Ge T, Patki A, Srinivasasainagendra V, Armstrong N, Davis B, et al.
Diabetes
. 2024 Mar;
73(6):993-1001.
PMID: 38470993
Article Highlights: